arrow
G

Gerhard Hildebrandt

University of Missouri System
H指数:46
被引数:9,198

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

lisocabtagene maraleucel用于不适合HSCT的R/R LBCL患者的治疗:PILOT研究2期最终结果

2025-05-050
OA
Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults

造血细胞移植后T细胞恢复延迟与成人总生存率降低相关

2025-04-210
OA
Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: Final Analysis of the Multicenter Phase II Randomized Clinical Trial

高压氧(HBO)对高剂量治疗和自体HSPC移植后多发性骨髓瘤患者血细胞计数恢复及移植结局的影响:多中心Ⅱ期随机临床试验的最终分析

BLOOD
IF23.1
2024-11-050
PRE
Late effects after allogeneic haematopoietic cell transplantation in children and adolescents with nonmalignant disorders: a retrospective cohort study
2024-10-011
PRE
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
2023-11-177
OAAI
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis
2023-07-288
OAAI
Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
2023-06-1519
OAAI
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
CANCER
IF5.1
2023-04-062
PRE
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients (oct, 10.1038/s41375-022-01738-3, 2022)
LEUKEMIA
IF13.4
2023-03-220
OA
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
2023-02-0920
OAAI
Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

调整接受异基因造血干细胞移植的患有血液系统恶性肿瘤的儿童,青少年和年轻人的hct-ci定义

2023-02-016
OAAI
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients
LEUKEMIA
IF13.4
2022-10-3011
OA
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy- an ancillary study of the SAKK 09/10 randomized clinical trial

在根治性前列腺切除术后接受挽救性放疗而无激素治疗的患者中验证Decipher基因组分类器-SAKK 09/10随机临床试验的辅助研究

2022-09-0128
OA
The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials
2022-09-014
OAAI
Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation
2022-08-011
OAAI